This company represents great value at 0.15. They were an absolute steal at 0.06 at the end of March when they announced that they'd acquired Echo IQ. They've partnered up with Edwards and NEDA for a fully-funded clinical trial. That's a decent vote of confidence. I look forward to how this one goes when the patents are secured and with FDA approval.
cheers
- Forums
- ASX - By Stock
- EIQ
- Ann: ECHOiQ Clinical Trial
Ann: ECHOiQ Clinical Trial, page-5
Featured News
Add EIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $64.37M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 13.0¢ | $3.858K | 29.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 122552 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 208925 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 122552 | 0.125 |
1 | 75000 | 0.120 |
3 | 292768 | 0.115 |
4 | 504495 | 0.110 |
1 | 100000 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 208925 | 3 |
0.135 | 457026 | 3 |
0.145 | 120000 | 1 |
0.150 | 403791 | 4 |
0.160 | 3400 | 1 |
Last trade - 11.26am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
13.0¢ |
  |
Change
-0.005 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
13.0¢ | 13.0¢ | 13.0¢ | 44500 | ||
Last updated 10.28am 07/05/2024 ? |
Featured News
EIQ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online